22.02.2018 12:59:00

Stepan Reports Fourth Quarter and Record Full Year 2017 Results

NORTHFIELD, Ill., Feb. 22, 2018 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported:

Fourth Quarter Highlights

  • Reported net income was $9.9 million, or $0.42 per diluted share versus $8.4 million, or $0.36 per diluted share, in the prior year. Adjusted net income was $24.6 million, or $1.06 per diluted share versus $12.3 million, or $0.52 per diluted share, in the prior year.* Current year adjusted net income excludes a $14.9 million net after-tax charge related to the new U.S. Tax Cuts and Jobs Act legislation.
  • Surfactant operating income was $28.3 million versus $14.6 million in the prior year. This increase was primarily attributable to $8.3 million of non-recurring expenses in the prior year, favorable resolution of a European product claim, growth in key global markets and improved internal efficiencies. Global Surfactant sales volume increased 2% versus the prior year.
  • Polymer operating income was $19.0 million versus $16.5 million in the prior year. This increase was mostly attributable to higher European Rigid Polyol and global Specialty Polyol volumes. Global Polymer volume was up 1% versus the prior year.
  • Specialty Product operating income was $2.3 million versus $4.2 million in the prior year primarily due to the timing of orders in our flavor business and lower volume and margins in our food business.
  • During the fourth quarter of 2017, the Company approved a plan to restructure a portion of its Fieldsboro, NJ production facility. The Company recorded $0.9 million of pre-tax severance expense and $1.3 million of accelerated depreciation for the areas that will be impacted by the shutdown. This decision was made to improve future asset utilization and reduce the Company's North American cost base going forward.

Full Year Highlights

  • Reported net income was a record $91.6 million, or $3.92 per diluted share, a 6% increase versus $86.2 million, or $3.73 per diluted share, in the prior year. Adjusted net income was a record $108.7 million, or $4.65 per diluted share, an 11% increase versus $98.2 million, or $4.25 per diluted share, in the prior year.* Current year adjusted net income excludes a $14.9 million net after-tax charge related to the new U.S. Tax Cuts and Jobs Act legislation.
  • 2017 marked the seventh record annual income over the last ten years.
  • The Surfactant segment delivered record operating income of $120.0 million, a 20% increase versus prior year. The Polymer segment delivered $82.8 million of operating income, a 14% decrease versus prior year. Despite being down versus prior year, the Polymer results were the second best on record. Specialty Product operating income was $10.0 million versus $10.7 million in the prior year.
  • Total company sales volume declined 1%. Most of the decline was attributable to lower commodity surfactant demand, partially offset by higher global Functional Products and Specialty Polyol end market demand.
  • The effect of foreign currency translation positively impacted net income by $1.0 million, or $0.04 per diluted share, versus prior year.
  • Free cash flow** for the year was $101 million versus $92 million in the prior year. The Company had no net debt at year-end.
  • The Company entered into a five year $350 million unsecured revolving line of credit in January 2018. The credit agreement allows the Company to make unsecured borrowings, as needed, for working capital and general corporate purposes, including acquisitions.

"2017 was a good year as the Company delivered record reported and adjusted net income," said F. Quinn Stepan, Jr., Chairman, President and Chief Executive Officer.  "Improved product mix, increased asset utilization and enhanced internal efficiencies continued to drive results.  Both Surfactants and Polymers benefited from our diversification strategy and we anticipate further contributions in 2018.

For the full year, Surfactants delivered record operating income due to improved product mix, lower manufacturing costs, and the accretive impact of our 2016 Brazil acquisition.  Sales benefited from our diversification efforts into functional products, higher sales within the household, industrial and institutional end markets and continued growth in more specialized applications. 

Polymers delivered its second best full year results despite increased competitive pressure and higher raw material costs within our North American Polyol business.  Global Polyol volumes were up slightly despite share loss in North America. The market for insulation materials remains strong due to continued global energy conservation efforts."

*  Adjusted net income is a non-GAAP measure which excludes deferred compensation income/ expense as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per share.

** Free cash flow is defined as cash flow from operations less capital expenditures and cash dividends paid.

 

 

Financial Summary












Three Months Ended

December 31



Twelve Months Ended

December 31


($ in thousands, except per share data)

2017



2016



%

Change



2017



2016



%

Change


Net Sales

$

473,823



$

420,636




13

%


$

1,925,007



$

1,766,166




9

%

Operating Income

$

30,831



$

9,932




210

%


$

146,160



$

126,193




16

%

Net Income

$

9,884



$

8,417




17

%


$

91,578



$

86,191




6

%

Earnings per Diluted Share

$

0.42



$

0.36




17

%


$

3.92



$

3.73




5

%

























Adjusted Net Income *

$

24,649



$

12,294




100

%


$

108,691



$

98,187




11

%

Adjusted Earnings per Diluted Share *

$

1.06



$

0.52




104

%


$

4.65



$

4.25




9

%

























* See Table II for reconciliations of non-GAAP Adjusted Net Income and Adjusted Earnings per
Diluted Share.

 

Summary of Fourth Quarter Adjusted Net Income Items

Adjusted net income excludes non-operational deferred compensation income/expense and other significant and infrequent or non-recurring items.

  • U.S. Tax Reform Impact: The fourth quarter includes $14.9 million of net after-tax charges related to the new U.S. Tax Cuts and Jobs Act legislation. The one-time net impact is comprised of a $19.4 million transition tax expense on certain unrepatriated earnings of foreign subsidiaries, partially offset by a $4.5 million favorable impact related to the re-measurement of net U.S. deferred tax liabilities at a lower future corporate tax rate.
  • Business Restructuring and Asset Impairments: The fourth quarter includes $0.2 million of decommissioning expense related to the Canadian plant closure announced in 2016 and $0.6 million of after-tax severance related to the plan to restructure the Fieldsboro, NJ plant site. The prior year quarter included $4.0 million of after-tax expense comprised of: (i) $1.3 million of severance and decommissioning costs related to the Canadian plant shutdown; (ii) a $1.3 million asset write-down at the Bahia, Brazil site; and (iii) a $1.4 million asset write-down related to engineering costs associated with a project that was canceled.
  • Deferred Compensation: The fourth quarter includes $1.0 million of after-tax income versus $2.7 million of after-tax expense in the prior year.
  • Contract Termination Settlement: The fourth quarter of 2016 included $2.8 million of after-tax income generated on a negotiated customer contract termination fee related to the Bahia, Brazil site.

Percentage Change in Net Sales

The 13% increase in quarterly net sales was primarily due to higher selling prices, which were mostly attributable to the pass through of certain higher raw material costs.  Current quarter net sales also benefited from a 1% increase in volume and a 3% positive impact of foreign currency translation.   

 



Three Months Ended

December 31, 2017



Twelve Months Ended

December 31, 2017


Volume



1

%



-1

%

Selling Price



9

%



9

%

Foreign Translation



3

%



1

%

Total



13

%



9

%

 

 

 

Segment Results













Three Months Ended

December 31



Twelve Months Ended

December 31


($ in thousands)


2017



2016



%

Change



2017



2016



%

Change


Net Sales

























Surfactants


$

324,174



$

282,549




15

%


$

1,297,555



$

1,181,563




10

%

Polymers


$

131,083



$

116,286




13

%


$

546,634



$

498,826




10

%

Specialty Products


$

18,566



$

21,801




(15)%



$

80,818



$

85,777




(6)%


Total Net Sales


$

473,823



$

420,636




13

%


$

1,925,007



$

1,766,166




9

%

 

 



Three Months Ended

December 31



Twelve Months Ended

December 31


($ in thousands, all amounts pre-tax)


2017



2016



%

Change



2017



2016



%

Change


Operating Income

























Surfactants


$

28,257



$

14,582




94

%


$

119,990



$

99,796




20

%

Polymers


$

19,029



$

16,510




15

%


$

82,801



$

96,788




(14)%


Specialty Products


$

2,250



$

4,249




(47)%



$

9,952



$

10,698




(7)%


Segment Operating Income


$

49,536



$

35,341




40

%


$

212,743



$

207,282




3

%

Corporate Expenses


$

(18,705)



$

(25,409)




(26)%



$

(66,583)



$

(81,089)




(18)%


    Consolidated Operating Income


$

30,831



$

9,932




210

%


$

146,160



$

126,193




16

%

 

Total fourth quarter operating income, excluding corporate expenses, increased $14.2 million, or 40%, versus the prior year quarter.  Total full year operating income, excluding corporate expenses, increased $5.5 million or 3% versus the prior year. 

  • Surfactant net sales were $324.2 million for the quarter, a 15% increase versus prior year. Selling prices increased 11% versus the prior year primarily due to the pass-through of certain higher raw material costs. Sales volume increased 2%, mostly due to higher demand in the Functional Product end markets and higher Distribution sales, partially offset by lower Consumer Product commodity volumes. The translation impact of a weaker U.S. dollar increased net sales by 2%. Surfactant operating income increased $13.7 million or 94% versus the prior year, primarily attributable to $8.3 million of non-recurring expenses in the prior year, settlement of a European product claim, savings from the Canadian plant shutdown and improved product mix and growth in Agriculture end markets in Europe. Also, the prior year acquisition in Brazil positively contributed to the current year quarter.
  • Polymer net sales were $131.1 million in the fourth quarter, a 13% increase versus prior year. Selling prices increased 8% primarily due to the pass-through of certain higher raw material costs. Sales volume increased 1% in the quarter primarily due to higher European Rigid Polyol volume and higher global Specialty Polyol volume. This growth was partially offset by lower North American Rigid Polyol and Phthalic Anhydride volumes. North American Rigid Polyol volume was down 2% due to lost share. The translation impact of a weaker U.S. dollar favorably impacted net sales by 4%. Operating income increased $2.5 million or 15% versus the prior year quarter. This increase was primarily attributable to the European Rigid Polyol and global Specialty Polyol volume growth and the non-recurrence of a scheduled Phthalic Anhydride maintenance shutdown in the prior year quarter. Higher North American raw material costs partially offset these benefits.
  • Specialty Products net sales were $18.6 million for the quarter, a $3.2 million decrease versus the prior year. Operating income declined $2.0 million versus the prior year quarter primarily due to the timing of orders in our flavor business and lower volume and margins in our food business.

 

Corporate Expenses










Three Months Ended

December 31


Twelve Months Ended

December 31

($ in thousands)


2017


2016


%

Change


2017


2016


%

Change

Total  -  Corporate Expenses


$

18,705


$

25,409



(26)%


$

66,583


$

81,089



(18)%

Deferred Compensation Expense/(Income) *


$

(406)


$

4,210


NM


$

4,857


$

16,805



(71)%

Restructuring and Asset Impairment Expense


$

1,271


$

6,003



(79)%


$

3,069


$

7,064



(57)%

Adjusted Corporate Expense


$

17,840


$

15,196



17%


$

58,657


$

57,220



3%














* See Table III for a discussion of deferred compensation plan accounting.



    

  • Corporate expenses, excluding deferred compensation and business restructuring expenses, increased $2.6 million versus the prior year quarter. Most of this increase was attributable to higher legal expense. Corporate expenses were up $1.4 million, or 3%, on a full year basis.

 

Income Taxes

The full year effective tax rate was 34.3% in 2017 compared to 24.3% in 2016.  This increase was primarily attributable to the enactment of the U.S. Tax Cuts and Jobs Act, which resulted in a net tax cost of $14.9 million in 2017. The one-time net impact of $14.9 million was a result of the $19.4 million transition tax expense on certain unrepatriated earnings of foreign subsidiaries, partially offset by the $4.5 million favorable impact related to the re-measurement of net U.S. deferred tax liabilities at a lower future corporate tax rate. The increase in the effective tax rate was partially offset by favorable nonrecurring discrete items. We expect the effective tax rate to be in the range of 20% to 23% in 2018.

Selected Balance Sheet Information

The Company's net debt level decreased $48.4 million for the quarter while the net debt to total net debt plus equity ratio dropped from 5% to -1%, reflecting cash balances in excess of total debt.  The decrease in net debt was attributable to a $34.8 million increase in cash combined with a $13.6 million decline in total debt.  The fourth quarter rise in cash was primarily attributable to improved working capital components. 

 

 ($ in millions)

12/31/17


9/30/17


6/30/17


3/31/17


12/31/16

Net Debt















Total Debt

$

290.8


$

304.4


$

304.4


$

316.7


$

317.0

Cash


298.9



264.1



223.8



197.8



225.7

Net Debt

$

(8.1)


$

40.3


$

80.6


$

118.9


$

91.3

Equity


740.1



734.9



707.3



673.2



634.6

Net Debt + Equity

$

732.0


$

775.2


$

787.9


$

792.1


$

725.9

Net Debt / (Net Debt + Equity)


-1%



5%



10%



15%



13%

 

 

 

The major working capital components were:

 

 ($ in millions)

12/31/17


9/30/17


6/30/17


3/31/17


12/31/16

Net Receivables

$

293.5


$

314.1


$

306.2


$

287.5


$

263.4

Inventories


172.7



163.7



178.4



189.8



173.7

Accounts Payable


(205.0)



(172.4)



(169.2)



(163.8)



(158.3)


$

261.2


$

305.4


$

315.4


$

313.5


$

278.8

 

The Company had full year capital expenditures of $78.6 million in 2017 versus $103.1 million in the prior year.

Outlook

"After record results in 2016 and 2017, we believe our Surfactant business will continue to benefit from our diversification efforts into functional products, new technologies, expanded sales into our broad customer base globally and the stabilization of commodity surfactant volumes.  However,

headwinds in our North America Polymer business related to lost share and lower margins will continue to challenge us in 2018," said F. Quinn Stepan, Jr., Chairman, President and Chief Executive Officer.  "Results will benefit from the lower U.S. corporate tax rate in 2018."  

Conference Call

Stepan Company will host a conference call to discuss its fourth quarter and full year 2017 results at 10:00 a.m. ET (9:00 a.m. CT) on February 22, 2018. The call can be accessed by phone and webcast. Telephone access will be available by dialing +1 (800) 659-3371, and the webcast can be accessed through the Investor Relations/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.

Supporting Slides

Slides supporting this press release will be made available at www.stepan.com under the Investor Relations center at approximately the same time as this press release is issued.

Corporate Profile

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries.  Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning compounds and in agricultural and oilfield solutions.  The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

Headquartered in Northfield, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL.  For more information about Stepan Company please visit the Company online at www.stepan.com

Contact: Matthew J. Eaken

(847) 446-7500

Tables follow

Certain information in this presentation consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 8-K and Form 10-Q reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to disruptions in production or accidents at manufacturing facilities, global competition, volatility of raw material and energy costs, disruptions in transportation or significant changes in transportation costs, reduced demand due to customer product reformulations or new technologies, the probability of future acquisitions and the uncertainties related to the integration of acquired businesses, maintaining and protecting intellectual property rights, international business risks, including currency exchange rate fluctuations, legal restrictions and taxes, the impact of changes in the tax code as a result of recent federal tax legislation and uncertainty as to how some of those changes may be applied, our ability to estimate and maintain appropriate levels of recorded liabilities, our debt covenants, our ability to access capital markets, downturns in certain industries and general economic downturns, global political, military, security or other instability, costs related to expansion or other capital projects, interruption or breaches of information technology systems, the costs and other effects of governmental regulation and legal and administrative proceedings and our ability to retain executive management and key personnel.

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

Table I

STEPAN COMPANY

For the Three and Twelve Months Ended December 31, 2017 and 2016

(Unaudited – in thousands, except per share data)















Three Months Ended

December 31






2017


2016


2017


2016


Net Sales


$

473,823


$

420,636


$

1,925,007


$

1,766,166


Cost of Sales



393,224



351,916



1,586,742



1,427,621


Gross Profit



80,599



68,720



338,265



338,545


Operating Expenses:














Selling



13,787



14,960



54,271



57,212


Administrative



21,665



19,835



76,041



75,185


Research, Development and Technical Services



13,451



13,780



53,867



56,086


Deferred Compensation (Income) Expense



(406)



4,210



4,857



16,805





48,497



52,785



189,036



205,288
















Business restructuring and asset impairments



1,271



6,003



3,069



7,064
















Operating Income



30,831



9,932



146,160



126,193
















Other Income (Expense):














Interest, Net



(2,826)



(3,350)



(11,444)



(13,205)


Other, Net



527



427



4,521



828





(2,299)



(2,923)



(6,923)



(12,377)
















Income Before Income Taxes



28,532



7,009



139,237



113,816


Provision for Income Taxes



18,646



(1,402)



47,690



27,618


Net Income



9,886



8,411



91,547



86,198


Net (Income) Loss Attributable to Noncontrolling Interests



(2)



6



31



(7)


Net Income Attributable to Stepan Company


$

9,884


$

8,417


$

91,578


$

86,191


Net Income Per Common Share Attributable to Stepan Company














Basic


$

0.43


$

0.37


$

3.99


$

3.78


Diluted


$

0.42


$

0.36


$

3.92


$

3.73


Shares Used to Compute Net Income Per Common

Share Attributable to Stepan Company














Basic



22,961



22,860



22,946



22,793


Diluted



23,426



23,335



23,377



23,094
















 

 

Table II

Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share















Three Months Ended

December 31


Twelve Months Ended

December 31


($ in thousands, except per
share amounts)


2017


EPS


2016


EPS


2017


EPS


2016


EPS


Net Income Reported


$

9,884


$

0.42


$

8,417


$

0.36


$

91,578


$

3.92


$

86,191


$

3.73






















































Deferred Compensation (Income) Expense


$

(1,006)


$

(0.04)


$

2,654


$

0.11


$

(40)


$

(0.00)


$

9,977


$

0.43


Business Restructuring


$

834


$

0.04


$

4,028


$

0.17


$

2,216


$

0.09


$

4,824


$

0.21


Contract Termination Settlement






$

(2,805)


$

(0.12)






$

(2,805)


$

(0.12)


US Tax Reform Impact


$

14,937


$

0.64






$

14,937


$

0.64
































Adjusted Net Income


$

24,649


$

1.06


$

12,294


$

0.52


$

108,691


$

4.65


$

98,187


$

4.25


 

* All amounts in this table are presented after-tax

The Company believes that certain measures that are not in accordance with generally accepted accounting principles (GAAP), when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and provide better clarity on the impact of non-operational items.  Internally, the Company uses this non-GAAP information as an indicator of business performance, and evaluates management's effectiveness with specific reference to these indicators.  These measures should be considered in addition to, and are neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP.

 

 

Reconciliation of Pre-Tax to After-Tax Adjustments









Three Months Ended

December 31


Twelve Months Ended

December 31


($ in thousands, except per
share amounts)


2017


EPS


2016


EPS


2017


EPS


2016


EPS


Pre-Tax Adjustments


























Deferred Compensation (Income) Expense


$

(1,622)





$

4,281





$

(65)





$

16,092





Business Restructuring



1,271






6,003





$

3,069





$

7,064





Contract Termination Settlement








(4,250)










$

(4,250)































   Total Pre-Tax Adjustments


$

(351)





$

6,034





$

3,004





$

18,906































Cumulative Tax Effect on Adjustments


$

179





$

(2,157)





$

(828)





$

(6,910)





US Tax Reform Impact


$

14,937










$

14,937




































After-Tax Adjustments


$

14,765


$

0.64


$

3,877


$

0.16


$

17,113


$

0.73


$

11,996


$

0.52


 

 

Table III

Deferred Compensation Plan

The full effect of the deferred compensation plan on quarterly pre-tax income was $1.6 million of income versus $4.3 million of expense in the prior year.  The year-to-date pretax impact was $0.1 million of income versus $16.1 million of expense in the prior year.  The accounting for the deferred compensation plan results in operating income when the price of Stepan Company common stock or mutual funds held in the plan fall and expense when they rise.  The Company also recognizes the change in value of mutual funds as investment income or loss.  The quarter end market prices of Stepan Company common stock are as follows:










2017



2016




12/31


9/30


6/30


3/31


12/31


9/30


6/30


3/31


Stepan Company


$

78.97


$

83.66


$

87.14


$

78.81


$

81.48


$

72.66


$

59.53


$

55.29



































 

 

The deferred compensation income statement impact is summarized below:








Three Months Ended

December 31


Twelve Months Ended

December 31

($ in thousands)


2017


2016


2017


2016

Deferred Compensation













Operating Income (Expense)


$

406


$

(4,210)


$

(4,857)


$

(16,805)

Other, net – Mutual Fund Gain (Loss)



1,216



(71)



4,922



713

Total Pretax


$

1,622


$

(4,281)


$

65


$

(16,092)

Total After Tax


$

1,006


$

(2,654)


$

40


$

(9,977)

 

 

Table IV

Effects of Foreign Currency Translation

The Company's foreign subsidiaries transact business and report financial results in their  respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because  foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation  affects period-to-period comparisons of financial statement items (i.e., because foreign  exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results).  Below is a table that presents the impact that  foreign currency translation had on the changes in consolidated net sales and various income line items for the three and twelve month periods ending December 31, 2017 as compared to 2016:



















 ($ in millions)


Three Months Ended

December 31

Increase (Decrease)


Increase

Due to Foreign

Currency

Translation


Twelve Months Ended

December 31



Increase

(Decrease)


Increase

Due to Foreign

Currency

Translation




2017


2016








2017


2016








Net Sales


$

473.8


$

420.6


$

53.2


$

12.4


$

1,925.0


$

1,766.2


$

158.8


$

9.9


Gross Profit



80.6



68.7



11.9



2.2



338.3



338.5



(0.2)



2.6


Operating Income



30.8



9.9



20.9



1.4



146.2



126.2



20.0



1.7


Pretax Income



28.5



7.0



21.5



1.3



139.2



113.8



25.4



1.6


       

 

Table V

Stepan Company

Consolidated Balance Sheets

December 31, 2017 and December 31, 2016










December 31
2017



December 31
2016


ASSETS









Current Assets


$

788,736



$

685,541


Property, Plant & Equipment, Net



598,443




582,714


Other Assets



83,682




85,635


Total Assets


$

1,470,861



$

1,353,890


LIABILITIES AND STOCKHOLDERS' EQUITY









Current Liabilities


$

320,253



$

297,265


Deferred Income Taxes



10,962




12,497


Long-term Debt



268,299




288,859


Other Non-current Liabilities



130,433




119,353


Total Stepan Company Stockholders' Equity



740,096




634,604


Noncontrolling Interest



818




1,312


Total Liabilities and Stockholders' Equity


$

1,470,861



$

1,353,890


 

 

Cision View original content:http://www.prnewswire.com/news-releases/stepan-reports-fourth-quarter-and-record-full-year-2017-results-300602404.html

SOURCE Stepan Company

Analysen zu Stepan CoShsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Stepan CoShs 73,50 0,68% Stepan CoShs